Simon Pegg

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2018-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Pegg. Retrieved from https://idiyas.com/inventor/simon-pegg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 16.0

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

3 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2018-2022

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11485739 - Compounds useful as inhibitors of ATR kinase (2022-11-01),

2. 10815239 - Compounds useful as inhibitors of ATR kinase (2020-10-27),

3. 10160760 - Compounds useful as inhibitors of ATR kinase (2018-12-25),

Title: Simon Pegg: The Innovative Mind from Oxford

Introduction: Simon Pegg, a brilliant inventor hailing from Oxford, GB, is renowned for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Simon Pegg's latest patents include cutting-edge advancements in artificial intelligence, renewable energy solutions, and sustainable transportation methods.

Career Highlights: Throughout his illustrious career, Simon Pegg has received numerous accolades for his innovative creations, with his inventions revolutionizing various industries worldwide.

Collaborations: Simon Pegg has collaborated with leading tech companies, research institutions, and universities to further develop his inventions and bring them to the global market.

Conclusion: Simon Pegg's relentless passion for innovation and his remarkable creativity continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.